These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23819487)

  • 41. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
    Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
    J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota.
    Dwyer MS; Melton LJ; Ballard DJ; Palumbo PJ; Trautmann JC; Chu CP
    Diabetes Care; 1985; 8(4):316-22. PubMed ID: 4042796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetic retinopathy and associated risk factors in type-1 and type-2 diabetics in the Upper Palatinate].
    Zietz B; Kasparbauer A; Ottmann S; Spiegel D; Palitzsch KD
    Dtsch Med Wochenschr; 2000 Jun; 125(25-26):783-8. PubMed ID: 10916493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance.
    Kashim RM; Newton P; Ojo O
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29351207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The English national screening programme for sight-threatening diabetic retinopathy.
    Scanlon PH
    J Med Screen; 2008; 15(1):1-4. PubMed ID: 18416946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
    Wang LZ; Cheung CY; Tapp RJ; Hamzah H; Tan G; Ting D; Lamoureux E; Wong TY
    Br J Ophthalmol; 2017 Oct; 101(10):1352-1360. PubMed ID: 28292772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
    Soto-Pedre E; Pinies JA; Hernaez-Ortega MC
    J Diabetes Complications; 2015; 29(4):508-11. PubMed ID: 25725582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of diabetic retinopathy in patients after ten years of diagnosis of type 2 diabetes mellitus.
    Shaikh MA; Gillani S; Dur-E-Yakta
    J Ayub Med Coll Abbottabad; 2010; 22(3):158-60. PubMed ID: 22338445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes.
    Soto-Pedre E; Hernaez-Ortega MC; Piniés JA
    Ophthalmic Epidemiol; 2007; 14(2):76-9. PubMed ID: 17464854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and progression of diabetic retinopathy: a systematic review.
    Sabanayagam C; Banu R; Chee ML; Lee R; Wang YX; Tan G; Jonas JB; Lamoureux EL; Cheng CY; Klein BEK; Mitchell P; Klein R; Cheung CMG; Wong TY
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):140-149. PubMed ID: 30005958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetic retinopathy and its relevance to paediatric age. An update.
    Porta M; Allione A
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):404-11. PubMed ID: 16437031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.
    Burgess PI; MacCormick IJ; Harding SP; Bastawrous A; Beare NA; Garner P
    Diabet Med; 2013 Apr; 30(4):399-412. PubMed ID: 22817387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community-based diabetic retinopathy screening in Hong Kong: ocular findings.
    Fung MM; Yap MK; Cheng KK
    Clin Exp Optom; 2011 Jan; 94(1):63-6. PubMed ID: 21198835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vibration perception threshold for sight-threatening retinopathy screening in type 2 diabetic outpatients.
    Shen J; Hu Y; Liu F; Zeng H; Li L; Zhao J; Zhao J; Zheng T; Lu H; Lu F; Bao Y; Jia W
    Diabetes Metab Res Rev; 2013 Oct; 29(7):525-31. PubMed ID: 23658123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of state of the organ of sight in patients with diabetes type II].
    Wilczyński M; Dziegielewski K
    Klin Oczna; 2005; 107(10-12):672-4. PubMed ID: 16619817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Programme preventing vision loss due to diabetes].
    Bandurska-Stankiewicz E; Wiatr D
    Klin Oczna; 2007; 109(7-9):359-62. PubMed ID: 18260299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova.
    Zatic T; Bendelic E; Paduca A; Rabiu M; Corduneanu A; Garaba A; Novac V; Curca C; Sorbala I; Chiaburu A; Verega F; Andronic V; Guzun I; Căpăţină O; Zamă-Mardari I
    Br J Ophthalmol; 2015 Jun; 99(6):832-6. PubMed ID: 25550353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England.
    Jones CD; Greenwood RH; Misra A; Bachmann MO
    Diabetes Care; 2012 Mar; 35(3):592-6. PubMed ID: 22279031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on Screening for Sight-Threatening Diabetic Retinopathy.
    Scanlon PH
    Ophthalmic Res; 2019; 62(4):218-224. PubMed ID: 31132764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Personalising screening of sight-threatening diabetic retinopathy - qualitative evidence to inform effective implementation.
    Byrne P; Thetford C; Gabbay M; Clarke P; Doncaster E; Harding SP;
    BMC Public Health; 2020 Jun; 20(1):881. PubMed ID: 32513143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.